The National Cancer Institute (NCI) is offering the SBIR Phase IIB Bridge Awards to accelerate the development of cancer-relevant technologies towards commercialization. This grant aims to support small businesses that were previously funded under SBIR or STTR Phase II awards from any Federal agency, facilitating the transition to the commercialization stage. The focus is on promoting partnerships with investors and strategic partners to expedite the commercialization process. Applicants must demonstrate independent third-party investor funding equal to or greater than the NCI funds. Projects can target preclinical and/or clinical stages of technology development, with clinical trials being optional. Closing date for applications is August 6, 2021.
Opportunity ID: 332369
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-036 |
| Funding Opportunity Title: | SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 25, 2021 |
| Last Updated Date: | Mar 25, 2021 |
| Original Closing Date for Applications: | Aug 06, 2021 |
| Current Closing Date for Applications: | Aug 06, 2021 |
| Archive Date: | Sep 11, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-036.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00266157 | Jul 06, 2021 | Aug 06, 2021 | View |
Package 1
Mandatory forms
332369 RR_SF424_2_0-2.0.pdf
332369 PHS398_CoverPageSupplement_5_0-5.0.pdf
332369 RR_OtherProjectInfo_1_4-1.4.pdf
332369 PerformanceSite_2_0-2.0.pdf
332369 RR_KeyPersonExpanded_2_0-2.0.pdf
332369 RR_Budget_1_4-1.4.pdf
332369 PHS398_ResearchPlan_4_0-4.0.pdf
332369 SBIR_STTR_Information_1_3-1.3.pdf
332369 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332369 RR_SubawardBudget30_1_4-1.4.pdf
332369 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
